Coffey A K, O'Sullivan D J, Homma S, Dousa T P, Valtin H
Department of Physiology, Dartmouth Medical School, Hanover, New Hampshire 03756.
Am J Physiol. 1991 Oct;261(4 Pt 2):F640-6. doi: 10.1152/ajprenal.1991.261.4.F640.
In mice with hereditary nephrogenic diabetes insipidus (NDI), the inability of vasopressin to increase hydraulic water permeability is reflected in a lack of intramembranous particle (IMP) clusters in apical membranes of inner medullary collecting ducts. The lack arises from anomalously high activity of one or two isozymes of adenosine 3',5'-cyclic monophosphate-phosphodiesterase (cAMP-PDE). We asked whether inhibition of these isozymes with rolipram and cilostamide would raise not only the tissue content of cAMP but also and simultaneously restore IMP clusters. Inner medullary collecting ducts from NDI mice were incubated in vitro. Tissue content of cAMP (fmol of cAMP per bundle) and number of IMP clusters (per 100 microns 2 of principal cell apical membrane) were, respectively: control, 44.8 +/- 13.0 and 4.16 +/- 1.49; arginine vasopressin (AVP), 31.7 +/- 8.0 and 3.98 +/- 1.56; rolipram and cilostamide, 109.7 +/- 21.0 and 58.09 +/- 15.74; and AVP plus rolipram and cilostamide, 305.7 +/- 75 and 48.63 +/- 11.03 (with the last four values showing significant difference from control and AVP only, respectively). In addition, treating NDI mice with rolipram and cilostamide in vivo reduced their high fluid turnover. We conclude that failure by AVP to increase cAMP in cells of collecting ducts, which results from anomalously high activity of one or two specific isozymes of cAMP-PDE, is the major or sole cause for the excretion of hypotonic urine in NDI mice (DI +/+ Severe strain).
在患有遗传性肾性尿崩症(NDI)的小鼠中,抗利尿激素无法增加水通透性,这反映在内髓集合管顶膜中缺乏膜内颗粒(IMP)簇。这种缺乏是由腺苷3',5'-环磷酸单酯磷酸二酯酶(cAMP-PDE)的一种或两种同工酶异常高活性引起的。我们研究了用咯利普兰和西洛酰胺抑制这些同工酶是否不仅会提高cAMP的组织含量,同时还能恢复IMP簇。将NDI小鼠的内髓集合管进行体外培养。cAMP的组织含量(每束cAMP的fmol数)和IMP簇的数量(每100平方微米主细胞顶膜)分别为:对照组,44.8±13.0和4.16±1.49;精氨酸抗利尿激素(AVP)组,31.7±8.0和3.98±1.56;咯利普兰和西洛酰胺组,109.7±21.0和58.09±15.74;AVP加咯利普兰和西洛酰胺组,305.7±75和48.63±11.03(最后四个值分别与对照组和仅AVP组有显著差异)。此外,在体内用咯利普兰和西洛酰胺治疗NDI小鼠可降低其高液体周转率。我们得出结论,由于cAMP-PDE的一种或两种特定同工酶异常高活性导致AVP无法增加集合管细胞中的cAMP,这是NDI小鼠(DI +/+ 严重品系)排泄低渗尿的主要或唯一原因。